Florida / New York

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

United Therapeutics Announces Agreement To Acquire Priority Review Voucher

December 28, 2020 United Therapeutics Corporation announced today an agreement to acquire a Rare Pediatric Disease Priority Review Voucher (PRV), which it plans to use with a forthcoming New Drug Application with the U.S. Food and Drug Administration. United Therapeutics advises the PRV entitles the holder to designate an new drug application for priority review […]